{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T02:23:51Z","timestamp":1761445431762,"version":"build-2065373602"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,25]]},"DOI":"10.7759\/cureus.95409","type":"journal-article","created":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T02:20:05Z","timestamp":1761445205000},"source":"Crossref","is-referenced-by-count":0,"title":["Spinal Muscular Atrophy in Colombia: Nationwide Incidence, Demographic Distribution, and Healthcare Challenges"],"prefix":"10.7759","author":[{"given":"Milena","family":"Villamil-Osorio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian Andres","family":"Correa-Arrieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Milena","family":"Castellar Leones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edna  Julieth","family":"Bobadilla-Quesada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Maradei-Anaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1590\/0004-282x20190073","article-title":"Observations from a nationwide vigilance program in medical care for spinal muscular atrophy patients in Chile","volume":"77","author":"Alvarez K","year":"2019","unstructured":"Alvarez K, Suarez B, Palomino MA, et al.. Observations from a nationwide vigilance program in medical care for spinal muscular atrophy patients in Chile. Arq Neuropsiquiatr. 2019, 77:470-7.","journal-title":"Arq Neuropsiquiatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.31698\/ped.48012021008","article-title":"Clinical, epidemiological, and genetic characterization of patients with spinal muscular atrophy: series of 26 pediatric patients (Article in Spanish)","volume":"48","author":"Franco-To\u00f1\u00e1nez C","year":"2021","unstructured":"Franco-To\u00f1\u00e1nez C, Godoy-S\u00e1nchez L CG. Clinical, epidemiological, and genetic characterization of patients with spinal muscular atrophy: series of 26 pediatric patients (Article in Spanish). Pediatria. 2021, 48:10.31698\/ped.48012021008","journal-title":"Pediatria"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-71","article-title":"Spinal muscular atrophy","volume":"6","author":"D'Amico A","year":"2011","unstructured":"D'Amico A, Mercuri E, Tiziano FD, Bertini E. Spinal muscular atrophy. Orphanet J Rare Dis. 2011, 6:71. 10.1186\/1750-1172-6-71","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0671-8","article-title":"Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review","volume":"12","author":"Verhaart IE","year":"2017","unstructured":"Verhaart IE, Robertson A, Wilson IJ, et al.. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis. 2017, 12:124. 10.1186\/s13023-017-0671-8","journal-title":"Orphanet J Rare Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914873","article-title":"Spinal muscular atrophy: an evolving scenario through new perspectives in diagnosis and advances in therapies","volume":"24","author":"Angilletta I","year":"2023","unstructured":"Angilletta I, Ferrante R, Giansante R, et al.. Spinal muscular atrophy: an evolving scenario through new perspectives in diagnosis and advances in therapies. Int J Mol Sci. 2023, 24:14873. 10.3390\/ijms241914873","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7090251","article-title":"New directions for SMA therapy","volume":"7","author":"Messina S","year":"2018","unstructured":"Messina S. New directions for SMA therapy. J Clin Med. 2018, 7:10.3390\/jcm7090251","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7154-1","article-title":"Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe","volume":"261","author":"Bladen CL","year":"2014","unstructured":"Bladen CL, Thompson R, Jackson JM, et al.. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. J Neurol. 2014, 261:152-63. 10.1007\/s00415-013-7154-1","journal-title":"J Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri E","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, et al.. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018, 28:103-15. 10.1016\/j.nmd.2017.11.005","journal-title":"Neuromuscul Disord"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2023.2206569","article-title":"Burden of disease of spinal muscular atrophy linked to chromosome 5q (5q-SMA) in Colombia","volume":"23","author":"Gil-Rojas Y","year":"2023","unstructured":"Gil-Rojas Y, Su\u00e1rez-Obando F, Amaya-Granados D, Prieto-Pinto L, Samac\u00e1-Samac\u00e1 D, Ortiz B, Hern\u00e1ndez F. Burden of disease of spinal muscular atrophy linked to chromosome 5q (5q-SMA) in Colombia. Expert Rev Pharmacoecon Outcomes Res. 2023, 23:671-82. 10.1080\/14737167.2023.2206569","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.36469\/63185","article-title":"Healthcare utilization, costs of care, and mortality among patients with spinal muscular atrophy","volume":"6","author":"Tan H","year":"2019","unstructured":"Tan H, Gu T, Chen E, Punekar R, Shieh PB. Healthcare utilization, costs of care, and mortality among patients with spinal muscular atrophy. J Health Econ Outcomes Res. 2019, 6:185-95. 10.36469\/63185","journal-title":"J Health Econ Outcomes Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel RS","year":"2016","unstructured":"Finkel RS, Chiriboga CA, Vajsar J, et al.. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet. 2016, 388:3017-26. 10.1016\/S0140-6736(16)31408-8","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13010110","article-title":"Health-related quality of life in spinal muscular atrophy patients and their caregivers-a prospective, cross-sectional, multi-center analysis","volume":"13","author":"Wohnrade C","year":"2023","unstructured":"Wohnrade C, Velling AK, Mix L, et al.. Health-related quality of life in spinal muscular atrophy patients and their caregivers-a prospective, cross-sectional, multi-center analysis. Brain Sci. 2023, 13:10.3390\/brainsci13010110","journal-title":"Brain Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807305788","article-title":"Consensus statement for standard of care in spinal muscular atrophy","volume":"22","author":"Wang CH","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES, et al.. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007, 22:1027-49. 10.1177\/0883073807305788","journal-title":"J Child Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2018.4","article-title":"Advances in therapy for spinal muscular atrophy: promises and challenges","volume":"14","author":"Groen EJ","year":"2018","unstructured":"Groen EJ, Talbot K, Gillingwater TH. Advances in therapy for spinal muscular atrophy: promises and challenges. Nat Rev Neurol. 2018, 14:214-24. 10.1038\/nrneurol.2018.4","journal-title":"Nat Rev Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.004","article-title":"Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics","volume":"28","author":"Finkel RS","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, et al.. Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018, 28:197-207. 10.1016\/j.nmd.2017.11.004","journal-title":"Neuromuscul Disord"},{"key":"ref16","article-title":"","year":"2017","unstructured":"Vital Statistics. Provisional Figures. Instituto Nacional de Estad\u00edsticas Chile, 2017. https:\/\/www.ine.gob.cl\/estadisticas\/sociales\/demografia-y-vitales\/nacimientos-matrimonios-y-defunciones."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-GMB-2023-0126","article-title":"Neonatal screening for spinal muscular atrophy: a pilot study in Brazil","volume":"46","author":"Oliveira Netto AB","year":"2023","unstructured":"Oliveira Netto AB, Brusius-Facchin AC, Lemos JF, et al.. Neonatal screening for spinal muscular atrophy: a pilot study in Brazil. Genet Mol Biol. 2023, 46:e20230126. 10.1590\/1678-4685-GMB-2023-0126","journal-title":"Genet Mol Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2021.08.002","article-title":"Epidemiological investigation of spinal muscular atrophy in Japan","volume":"44","author":"Ito M","year":"2022","unstructured":"Ito M, Yamauchi A, Urano M, Kato T, Matsuo M, Nakashima K, Saito K. Epidemiological investigation of spinal muscular atrophy in Japan. Brain Dev. 2022, 44:2-16. 10.1016\/j.braindev.2021.08.002","journal-title":"Brain Dev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2016.07.017","article-title":"Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina","volume":"20","author":"Medrano S","year":"2016","unstructured":"Medrano S, Monges S, Gravina LP, et al.. Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy children from Argentina. Eur J Paediatr Neurol. 2016, 20:910-7. 10.1016\/j.ejpn.2016.07.017","journal-title":"Eur J Paediatr Neurol"},{"key":"ref20","article-title":"Hammersmith functional rating scale for children with spinal muscular atrophy. Validation of the Spanish version (Article in Spanish)","volume":"53","author":"Febrer A","year":"2011","unstructured":"Febrer A, Vigo M, Fagoaga J, Medina-Cantillo J, Rodr\u00edguez N, Tizzano E. Hammersmith functional rating scale for children with spinal muscular atrophy. Validation of the Spanish version (Article in Spanish). Rev Neurol. 2011, 53:657-63.","journal-title":"Rev Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2021.100899","article-title":"Spinal muscular atrophy treatments, newborn screening, and the creation of a neurogenetics urgency","volume":"38","author":"Butterfield RJ","year":"2021","unstructured":"Butterfield RJ. Spinal muscular atrophy treatments, newborn screening, and the creation of a neurogenetics urgency. Semin Pediatr Neurol. 2021, 38:100899. 10.1016\/j.spen.2021.100899","journal-title":"Semin Pediatr Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijns7030045","article-title":"Spinal muscular atrophy: diagnosis, incidence, and newborn screening in Japan","volume":"7","author":"Kimizu T","year":"2021","unstructured":"Kimizu T, Ida S, Okamoto K, et al.. Spinal muscular atrophy: diagnosis, incidence, and newborn screening in Japan. Int J Neonatal Screen. 2021, 7:10.3390\/ijns7030045","journal-title":"Int J Neonatal Screen"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000275492","article-title":"Incidence of spinal muscular atrophy in Poland--more frequent than predicted?","volume":"34","author":"Jedrzejowska M","year":"2010","unstructured":"Jedrzejowska M, Milewski M, Zimowski J, et al.. Incidence of spinal muscular atrophy in Poland--more frequent than predicted?. Neuroepidemiology. 2010, 34:152-7. 10.1159\/000275492","journal-title":"Neuroepidemiology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2024.1","article-title":"A study on the incidence and prevalence of 5q spinal muscular atrophy in Canada using multiple data sources","volume":"51","author":"Price TR","year":"2024","unstructured":"Price TR, Hodgkinson V, Westbury G, et al.. A study on the incidence and prevalence of 5q spinal muscular atrophy in Canada using multiple data sources. Can J Neurol Sci. 2024, 51:660-71. 10.1017\/cjn.2024.1","journal-title":"Can J Neurol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/ijns8040052","article-title":"Changes in the incidence of infantile spinal muscular atrophy in Shikoku, Japan between 2011 and 2020","volume":"8","author":"Okamoto K","year":"2022","unstructured":"Okamoto K, Nishio H, Motoki T, et al.. Changes in the incidence of infantile spinal muscular atrophy in Shikoku, Japan between 2011 and 2020. Int J Neonatal Screen. 2022, 8:10.3390\/ijns8040052","journal-title":"Int J Neonatal Screen"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320410216","article-title":"Prevalence of type I spinal muscular atrophy in North Dakota","volume":"41","author":"Burd L","year":"1991","unstructured":"Burd L, Short SK, Martsolf JT, Nelson RA. Prevalence of type I spinal muscular atrophy in North Dakota. Am J Med Genet. 1991, 41:212-5. 10.1002\/ajmg.1320410216","journal-title":"Am J Med Genet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-0186-1","article-title":"High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients","volume":"250","author":"Bouhouche A","year":"2003","unstructured":"Bouhouche A, Benomar A, Birouk N, Bouslam N, Ouazzani R, Yahyaoui M, Chkili T. High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients. J Neurol. 2003, 250:1209-13. 10.1007\/s00415-003-0186-1","journal-title":"J Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/414531-spinal-muscular-atrophy-in-colombia-nationwide-incidence-demographic-distribution-and-healthcare-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T02:20:11Z","timestamp":1761445211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/414531-spinal-muscular-atrophy-in-colombia-nationwide-incidence-demographic-distribution-and-healthcare-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.95409","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,25]]}}}